|
Name |
Sydowinin A
|
Molecular Formula | C16H12O6 | |
IUPAC Name* |
methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate
|
|
SMILES |
COC(=O)C1=C2C(=CC=C1)OC3=CC(=CC(=C3C2=O)O)CO
|
|
InChI |
InChI=1S/C16H12O6/c1-21-16(20)9-3-2-4-11-13(9)15(19)14-10(18)5-8(7-17)6-12(14)22-11/h2-6,17-18H,7H2,1H3
|
|
InChIKey |
UBYOEDLUKKPPPN-UHFFFAOYSA-N
|
|
Synonyms |
SYDOWININ A; 58450-01-4; ZS4IVQ1908; CHEBI:68227; methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate; Methyl 8-hydroxy-6-(hydroxymethyl)-9-oxo-xanthene-1-carboxylate; methyl 8-hydroxy-6-(hydroxymethyl)-9-oxo-9H-xanthene-1-carboxylate; 9H-Xanthene-1-carboxylic acid, 8-hydroxy-6-(hydroxymethyl)-9-oxo-, methyl ester; UNII-ZS4IVQ1908; MEGxm0_000150; CHEMBL1812028; ACon1_000704; DTXSID00635917; ZINC14455391; NCGC00169440-01; BRD-K19034484-001-01-6; Q27136720; NCGC00169440-02!methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate
|
|
CAS | 58450-01-4 | |
PubChem CID | 23872092 | |
ChEMBL ID | CHEMBL1812028 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 300.26 | ALogp: | 2.1 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.557 |
Caco-2 Permeability: | -4.93 | MDCK Permeability: | 0.00001240 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.234 |
Human Intestinal Absorption (HIA): | 0.034 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.965 |
Blood-Brain-Barrier Penetration (BBB): | 0.108 | Plasma Protein Binding (PPB): | 86.65% |
Volume Distribution (VD): | 0.944 | Fu: | 14.96% |
CYP1A2-inhibitor: | 0.97 | CYP1A2-substrate: | 0.811 |
CYP2C19-inhibitor: | 0.489 | CYP2C19-substrate: | 0.069 |
CYP2C9-inhibitor: | 0.757 | CYP2C9-substrate: | 0.858 |
CYP2D6-inhibitor: | 0.737 | CYP2D6-substrate: | 0.321 |
CYP3A4-inhibitor: | 0.499 | CYP3A4-substrate: | 0.141 |
Clearance (CL): | 2.968 | Half-life (T1/2): | 0.846 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.059 |
Drug-inuced Liver Injury (DILI): | 0.879 | AMES Toxicity: | 0.413 |
Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.063 |
Skin Sensitization: | 0.524 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.917 |
Respiratory Toxicity: | 0.08 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002106 | 0.776 | D0K8KX | 0.344 | ||||
ENC002668 | 0.722 | D04AIT | 0.322 | ||||
ENC002690 | 0.722 | D06GCK | 0.313 | ||||
ENC004885 | 0.671 | D0Z3DY | 0.312 | ||||
ENC002283 | 0.671 | D0G5UB | 0.301 | ||||
ENC005347 | 0.657 | D0G7IY | 0.300 | ||||
ENC003785 | 0.653 | D0U0OT | 0.295 | ||||
ENC002135 | 0.590 | D0QD1G | 0.295 | ||||
ENC002284 | 0.587 | D06NSS | 0.289 | ||||
ENC004886 | 0.587 | D0H2ZW | 0.284 |